Cargando…

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus

Acute heart failure (AHF) emerges as a major and growing epidemiological concern with high morbidity and mortality rates. Current therapies in patients with acute heart failure rely on different strategies. Patients with hypotension, hypoperfusion, or shock require inotropic support, whereas diureti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagy, László, Pollesello, Piero, Papp, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2014
Materias:	Drugs in the Pipeline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232335/ https://www.ncbi.nlm.nih.gov/pubmed/24785346 http://dx.doi.org/10.1097/FJC.0000000000000113

Ejemplares similares

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Short-term treatments for acute cardiac care: inotropes and inodilators
por: Guarracino, Fabio, et al.
Publicado: (2020)

Differential effects of inotropes and inodilators on renal function in acute cardiac care
por: Zima, Endre, et al.
Publicado: (2020)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

FDA review times for new drugs in ophthalmology
por: Carpenter, Michelle A., et al.
Publicado: (2020)

Five variables that rule your life – Home mortgage and biostatistical power
por: Novack, Gary D.
Publicado: (2020)

Repurposing medications
por: Novack, Gary D.
Publicado: (2021)

What is an adequate and well controlled study?
por: Novack, Gary D.
Publicado: (2021)

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

Compounded medications for ocular surface disease
por: Lee, Edward H., et al.
Publicado: (2021)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Special features of RAD Sequencing data: implications for genotyping
por: Davey, John W, et al.
Publicado: (2013)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience
por: Zotzmann, Viviane, et al.
Publicado: (2019)

The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
por: Burashnikov, Alexander
Publicado: (2020)

Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience—an RCT would be desirable
por: Jouffroy, Romain, et al.
Publicado: (2020)

Facing up to the challenges of acute heart failure
por: Pollesello, Piero
Publicado: (2020)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

EST Pipeline System: Detailed and Automated EST Data Processing and Mining
por: Xu, Hao, et al.
Publicado: (2003)

Inodilators in septic shock: should these be used?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine
por: Papp, Zoltán, et al.
Publicado: (2023)

Effects of Widespread Inotrope Use in Acute Heart Failure Patients
por: Kang, Jeehoon, et al.
Publicado: (2018)

Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure
por: Kelly, Julie, et al.
Publicado: (2020)

Heart failure induced by itraconazole
por: Okuyan, Hızır, et al.
Publicado: (2013)

Inotropes do not increase mortality in advanced heart failure
por: Guglin, Maya, et al.
Publicado: (2014)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

The JCSG high-throughput structural biology pipeline
por: Elsliger, Marc-André, et al.
Publicado: (2010)

TOPSAN: use of a collaborative environment for annotating, analyzing and disseminating data on JCSG and PSI structures
por: Krishna, S. Sri, et al.
Publicado: (2010)

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009)

Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?
por: Gulin, Dario, et al.
Publicado: (2019)

Hemodynamic effects of inotropic drugs in heart failure: A network meta-analysis of clinical trials
por: Long, Ling, et al.
Publicado: (2019)

Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014)

Acute hepatic failure due to yellow phosphorus ingestion
por: Mauskar, Anupama, et al.
Publicado: (2011)

Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice
por: Bistola, Vasiliki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pn5ms6r1fhmi0nkk20e097g5al